Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
10x Genomics (TXG) had Pre-Tax Income of $-15.19M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$166.03M |
|
$-16.25M |
|
$52.98M |
|
$113.05M |
|
$185.57M |
|
$-19.54M |
|
$4.35M |
|
|
Pre-Tax Income |
$-15.19M |
$-15.19M |
|
$-16.25M |
|
$-16.25M |
|
$-16.25M |
|
$-16.25M |
|
$-19.54M |
|
$-8.26M |
|
124.75M |
|
124.75M |
|
$-0.13 |
|
$-0.13 |
|
| Balance Sheet Financials | |
$684.45M |
|
$226.71M |
|
$356.91M |
|
$1.04B |
|
$153.45M |
|
-- |
|
$91.58M |
|
$245.04M |
|
$796.33M |
|
$729.49M |
|
$796.33M |
|
127.69M |
|
| Cash Flow Statement Financials | |
$136.05M |
|
$-13.44M |
|
$6.80M |
|
$344.07M |
|
$473.97M |
|
$129.90M |
|
$109.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.46 |
|
-- |
|
-- |
|
-- |
|
-- |
|
68.09% |
|
-11.77% |
|
-11.77% |
|
-- |
|
-9.15% |
|
-9.79% |
|
$130.12M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
0.94 |
|
2.01 |
|
44.72 |
|
-2.04% |
|
-2.23% |
|
-1.56% |
|
-2.04% |
|
$6.24 |
|
$1.04 |
|
$1.09 |
|